Disclosed is a liquid formulation comprising: a)an oligonucleotide comprising SEQ ID NO: 1 or comprising a variant oligonucleotide in which no more than 3 non-sequential bases are different from SEQ ID NO: 1 and b)an aqueous carrier comprising an aggregation-preventing compound selected from the group consisting of mono and disaccharides and/or sugar alcohols, wherein the oligonucleotide is present at a concentration of at least 25 mg/ml, and wherein the sequence is as defined in the complete specification.
